Homoeopathic treatment for Allergic rhinitis

Phase 2/3

Not yet recruiting

• Conditions: Allergic rhinitis, unspecified,

• Registration Number: CTRI/2020/11/028785
• Lead Sponsor: Mahesh Bhattacharyya Homoeopathic Medical College Hospital

Brief Summary

Allergic rhinitis (AR) is a major problem worldwide and millions of people are suffering from this condition. Homoeopathy has long been recognised for its effectiveness in AR. However, very few clinical trials are there evaluating the effect of Individualised Homoeopathy in AR cases. This study has been taken up to demonstrate the feasibility and effect of IH in such cases. The trial will be conducted in strict adherence to the Helsinki’s human declaration protocol. The results of this study will be of much interest to the therapeutic modalities for AR.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-11
• Last Update Posted: 2020-10-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• 1.Patient suffering from Allergic rhinitis (AR) for at least 1 year.
• Confirmative diagnosis of AR by medical history, symptoms, skin prick tests (SPTs) or other biochemical parameters.
• 2.Subject must be symptomatic at screening and willing to maintain same environment throughout the study.
• 3.Ability to read and write English or Bengali 4.Ability and willingness to comply with study procedures.

Exclusion Criteria

• 1.Having complications of the nasal disease, or vasomotor rhinitis, rhinitis with eosinophilia, or drug rhinitis 2.Having complications of bacterial/viral infection of the upper respiratory tract 3.Having a significant systemic disease or any organ failure.
• 4.Subject suffering from any life threatening/Psychiatric/ illnesses or Immuno-compromised state or other significant disease conditions.
• 5.Pregnant or lactating woman 6.Substance abuse or dependence 7.Patients planning to travel outside the region 8.Patients who participated in another study within 4 months before screening 9.Patients taking drugs for other illness 10.Patients who have taken any homoeopathic medicines in the last 3 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total Nasal Symptom Score (TNSS)	baseline, 1st week, 2nd week, 3rd week and 4th week

Secondary Outcome Measures

Name	Time	Method
Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ)	baseline, 1st week, 2nd week, 3rd week and 4th week

Trial Locations

Locations (1)

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital; 🇮🇳 Haora, WEST BENGAL, India

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

🇮🇳Haora, WEST BENGAL, India

Dr Smriti Das

Principal investigator

09903827399

drdassmriti@gmail.com